Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine 2% vs 4% in Third Molar Extraction
NCT02457325Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of articaine in impacted third molar (I3M), sponsored by Universidade de São Paulo. Started Jun 2011; status: completed.
02
Drugs
articaine
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT02457325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457325.